Ridgefield, CT, United States of America

Fredrik Lars Nordstrom

This inventor holds 11 USPTO granted patents and 14 published patent applications, plus 8 CIPO patents and 1 EPO patent. Top assignees: Abbvie Inc., Boehringer Ingelheim International Gmbh. Active years: 2019-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Fredrik Lars Nordstrom. Retrieved from https://idiyas.com/inventor/fredrik-lars-nordstrom

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 11 (Patent Applications = 14)

% Patents Active = 100.0

CIPO Patents = 8 (Patent Applications = 4)

EPO Patents = 1 (Patent Applications = 9)

Average Co-Inventor Count = 7.1

ph-index = 6

Forward Citations = 124(Granted Patents)

Company Filing History:

Boehringer Ingelheim International Gmbh

patents

Years Active: 2019-2025

Loading Chart...

11 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12275722 - Process of reworking a crystalline form of a glycine transport inhibitor (2025-04-14),

2. 12110298 - Processes for the preparation of (3S,4R)-3-ethyl-4-(3H-imidazo[1,2-a]pyrrolo[2,3-e]-pyrazin-8-yl)-N-(2,2,2-trifluoroethyl)pyrrolidine-1-carboxamide and solid state forms thereof (2024-10-08),

3. 11680069 - Processes for the preparation of (3S,4R)-3-ethyl-4-(3H-imidazo[1,2-a]pyrrolo[2,3-e]-pyrazin-8-yl)-n-(2,2,2-trifluoroethyl)pyrrolidine-1-carboxamide and solid state forms thereof (2023-06-20),

4. 11661425 - Processes for the preparation of (3S,4R)-3-ethyl-4-(3H-imidazo[1,2-a]pyrrolo[2,3-e]-pyrazin-8-yl)-N-(2,2,2-trifluoroethyl)pyrrolidine-1-carboxamide and solid state forms thereof (2023-05-30),

5. 11512092 - Processes for the preparation of (3S,4R)-3-ethyl-4-(3H-imidazo[1,2-a]pyrrolo[2,3-e]-pyrazin-8-yl)-n-(2,2,2-trifluoroethyl)pyrrolidine-1-carboxamide and solid state forms thereof (2022-11-29),

6. 11198697 - Processes for the preparation of (3S,4R)-3-ethyl-4-(3H-imidazo[1,2-a]pyrrolo[2,3-e]-pyrazin-8-yl)-N-(2,2,2-trifluoroethyl)pyrrolidine-1-carboxamide and solid state forms thereof (2021-12-14),

7. 11186584 - Processes for the preparation of (3S,4R)-3-ethyl-4-(3H-imidazo[1,2-a]pyrrolo[2,3-e]-pyrazin-8-yl)-n-(2,2,2-trifluoroethyl)pyrrolidine-1-carboxamide and solid state forms thereof (2021-11-30),

8. 11046648 - Transition metal-catalyzed protodecarboxylation of α-halo-acrylic acid derivatives (2021-06-29),

9. 10981923 - Processes for the preparation of (3S,4R)-3-ethyl-4-(3H-imidazo[l,2-a]pyrrolo[2,3-e]-pyrazin-8-yl)-N-(2,2,2-trifluoroethyl)pyrrolidine-1-carboxamide and solid state forms thereof (2021-04-20),

10. 10654803 - Transition metal-catalyzed protodecarboxylation of alpha-halo-acrylic acid derivatives (2020-05-19),

11. 10252994 - Transition metal-catalyzed protocarboxylation of α-halo-acrylic acid derivatives (2019-04-09),

Title: Fredrik Lars Nordstrom: Innovator in Pharmaceutical Processes

Introduction

Fredrik Lars Nordstrom, an accomplished inventor based in Ridgefield, CT, holds a notable portfolio of 11 patents. His innovative work primarily focuses on the pharmaceutical industry, specifically on processes related to drug formulation and crystallization.

Latest Patents

Among his latest patents is a groundbreaking invention related to the "Process of reworking a crystalline form of a glycine transport inhibitor." This invention details a method for reworking crystallization products through drying and homogenization. The specific crystallization product involves a complex compound, highlighting Nordstrom's expertise in chemical formulations.

Another significant patent involves "Processes for the preparation of (3S,4R)-3-ethyl-4-(3H-imidazo[1,2-a]pyrrolo[2,3-e]pyrazin-8-yl)-N-(2,2,2-trifluoroethyl)pyrrolidine-1-carboxamide and solid-state forms thereof." This disclosure outlines the preparation methods for this compound, as well as its pharmaceutical applications, including potential treatments for conditions like rheumatoid arthritis.

Career Highlights

Fredrik has had a distinguished career, contributing his expertise at prominent pharmaceutical companies such as AbbVie Inc. and Boehringer Ingelheim International GmbH. His work in these organizations has led to significant advancements in drug products and processes, solidifying his reputation as a leader in pharmaceutical innovation.

Collaborations

Throughout his career, Nordstrom has collaborated with talented professionals, including Ahmad Y Sheikh and Ayman Allian. These partnerships have been instrumental in driving forward various projects, expanding the scope and impact of his innovations.

Conclusion

Fredrik Lars Nordstrom's contributions to the field of pharmaceuticals through his 11 patents demonstrate his commitment to advancing medical science. His innovative processes not only enhance drug formulations but also offer potential solutions for treating various ailments, reflecting his substantial impact on the industry. As he continues to push the boundaries of pharmaceutical research, Nordstrom remains a key figure in innovation and invention within the sector.

Profile summary based on public USPTO records.